Autism spectrum disorder: a neuro-immunometabolic hypothesis of the developmental origins.
Fetal neuroinflammation and prenatal stress (PS) may contribute to lifelong neurological disabilities. Astrocytes and microglia play a pivotal role, but the mechanisms are poorly understood. Here, we test the hypothesis that via gene-environment interactions, fetal neuroinflammation and PS may reprogram glial immunometabolic phenotypes which impact neurodevelopment and neurobehavior. This glial-neuronal interplay increases the risk for clinical manifestation of autism spectrum disorder (ASD) in at-risk children. Drawing on genomic data from the recently published series of ovine and rodent glial transcriptome analyses with fetuses exposed to neuroinflammation or PS, we conducted a secondary analysis against the Simons Foundation Autism Research Initiative (SFARI) Gene database. We confirmed 21 gene hits. Using unsupervised statistical network analysis, we then identified six clusters of probable protein-protein interactions mapping onto the immunometabolic and stress response networks and epigenetic memory. These findings support our hypothesis. We discuss the implications for ASD etiology, early detection, and novel therapeutic approaches.